People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xagenic Inc. | — | Biotechnology | Series A | $9.6M | $346.6M | 2013 |
Yuri D. Kuzyk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yuri D. Kuzyk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jesse A. Treu, Ph.D. | 1 | 1 |
| Jack D. Graham | 1 | 1 |
| Shana Kelley, Ph.D. | 1 | 1 |
| Ihor A. Boszko | 1 | 1 |
| Erik A. Holmlin, Ph.D., M.B.A. | 1 | 1 |
| Shermaine A. Tilley, Ph.D., M.B.A. | 1 | 1 |
| Bruce A. Cohen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.